New Research Reinforces the Recommendation to Start Offering HPV Vaccines at Age Nine
Read NEW evidence, recently published, on the impact of initiating HPV vaccination at ages 9-10, including population studies, quality improvement projects, brief reports, and commentaries from experts in the field. The collection of 10+ published articles shows the benefits, effectiveness, and acceptability of routinely recommending HPV vaccination for all preteens starting at age nine.
Giving a strong recommendation for HPV vaccination at age 9 will increase vaccine completion success and prevent more cancers.
Visit our Resource Library to download our Age 9 resources which include:
– Communication Toolkit
– Core Age 9 Messages
– Evidence Summary
– National Call to Action Letter
– 9 Benefits of Age 9 YouTube Video
– Print-on-Demand Provider Toolkits
– Toolboxes for providers, health systems, advocacy, parents, and health departments
– Why Age 9 Fact Sheet